CARsgen Therapeutics Holdings Limited (Hong Kong) (China)

CARsgen Therapeutics Holdings Limited is a national high-tech enterprise based in Hong Kong. The company specializes in the research and production of "chemiluminescent immunoassay instruments and in vitro diagnostic reagents." Since its establishment, CARsgen Therapeutics Holdings Limited has focused on the research of chemiluminescent immunoassay technology in the field of in vitro diagnostics. After 15 years of dedicated efforts, the company successfully launched China's first fully automated chemiluminescent immunoassay instrument and its corresponding reagents in February 2010. CARsgen Therapeutics Holdings Limited is the first company in China to use advanced "nano-immunomagnetic microspheres" as the key separation material in the system, the first to use "artificially synthesized small organic molecules" as luminescent markers instead of traditional enzymes, and the first to apply direct chemiluminescent immunoassay technology and achieve mass production of fully automated chemiluminescent immunoassay instruments and reagents. The company's research achievements have filled the gap in the field of in vitro diagnostics in China, breaking the long-standing monopoly and technological blockade by foreign manufacturers in this field. CARsgen Therapeutics Holdings Limited has become a leader in the field of chemiluminescent immunoassay quantitative analysis in China.